Patients with a progression-free interval (PFI) of 3–6 months saw substantial benefits from platinum rechallenge.
In the medical field, is the identification number for a significant retrospective cohort study titled "A real-world retrospective cohort study: the clinical outcomes and safety of platinum rechallenge in patients with platinum-resistant recurrent ovarian cancer (PRROC)." 100717
For hobbyists, 100717 is a thread identifier on the Black Phoenix Alchemy Lab (BPAL) forums, specifically discussing the " The Picture of Dorian Sufganiyot " fragrance review. Patients with a progression-free interval (PFI) of 3–6
Establishing the initial code base required for translation. 100717
Moving existing hard-coded diagnostics into the new system.